Literature DB >> 9491318

Cytogenetic and molecular analysis of a t(1;22)(p36;q11.2) in a rhabdoid tumor with a putative homozygous deletion of chromosome 22.

C Rosty1, M Peter, J Zucman, P Validire, O Delattre, A Aurias.   

Abstract

Malignant rhabdoid tumors are rare and aggressive neoplasms of childhood, occurring in the kidney or in various extrarenal locations. Most cytogenetic studies of these tumors have shown the frequent involvement of chromosome 22, including translocations and/or deletions, with a critical region for a rhabdoid tumor gene mapping to chromosome segment 22q11, close to BCR. We report a case of an extrarenal rhabdoid tumor with a t(1;22)(p36;q11.2) that was associated with deletions of chromosomes 1 and 22. We have performed fluorescence in situ hybridization to bracket the translocation breakpoints on both chromosomes and microsatellite analysis to establish the deletion of chromosome 22 more precisely. The chromosome 22 translocation breakpoint is localized close to BCR, in the region covered by the overlapping YACs 446B5 and 361D9, and it is associated with a proximal hemizygous deletion of approximatively 2 Mb. On chromosome 1, the translocation breakpoint maps to a 25 cM region, proximal to D1Z2 and distal to PND, and is also associated with an estimated deletion of 8 Mb. Moreover, microsatellite analysis has demonstrated a homozygous deletion of chromosome 22 for three contiguous loci, immediately distal to BCR. This result suggests that a tumor suppressor gene involved in rhabdoid tumor oncogenesis could be localized in this region of chromosome 22.

Entities:  

Mesh:

Year:  1998        PMID: 9491318

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers.

Authors:  N Sévenet; E Sheridan; D Amram; P Schneider; R Handgretinger; O Delattre
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  Translocation (1;22)(p36;q11.2) with concurrent del(22)(q11.2) resulted in homozygous deletion of SNF5/INI1 in a newly established cell line derived from extrarenal rhabdoid tumor.

Authors:  Akiko Misawa; Hajime Hosoi; Issei Imoto; Tomoko Iehara; Tohru Sugimoto; Johji Inazawa
Journal:  J Hum Genet       Date:  2004-09-18       Impact factor: 3.172

Review 3.  Case-based review: atypical teratoid/rhabdoid tumor.

Authors:  Cody L Nesvick; Amulya A Nageswara Rao; Aditya Raghunathan; Jaclyn A Biegel; David J Daniels
Journal:  Neurooncol Pract       Date:  2018-10-05

4.  hSNF5 /INI1 mutation analysis in acute myeloid leukemia.

Authors:  Yu-Chieh Su; Chao-Bin Chen; Ya-Ting Chang; Ya-Ting Tung; Dian-Kun Li
Journal:  Int J Hematol       Date:  2008-02-13       Impact factor: 2.490

5.  Surgery and actinomycin improve survival in malignant rhabdoid tumor.

Authors:  Ryan Horazdovsky; J Carlos Manivel; Edward Y Cheng
Journal:  Sarcoma       Date:  2013-02-03

6.  Imaging features of spinal atypical teratoid rhabdoid tumors in children.

Authors:  Hui-Ying Wu; Wen-Biao Xu; Lian-Wei Lu; He-Hong Li; Jin-Sheng Tian; Jian-Ming Li; Zheng-Rong Chen
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.